Epidemiology of head injuries in pedestrian-motor vehicle accidents.
Corbus sees Novo’s controversial obesity approach as a ticket to a blockbuster
NEW YORK — Nearly two decades ago, European regulators pulled an obesity drug called rimonabant off the market due to concerns it was tied to suicidal